Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
Background: The substitution of generic drugs can effectively alleviate the rapid growth of drug costs; however, the clinical effectiveness and medical costs of originator products and generics were barely studied in China.Objectives: To compare the effectiveness of antihypertensive drugs and hypert...
Saved in:
Main Authors: | Tao Huang (Author), Lin Bai (Author), Haishaerjiang Wushouer (Author), Zhiyuan Wang (Author), Mingchun Yang (Author), Hongbo Lin (Author), Peng Shen (Author), Xiaodong Guan (Author), Luwen Shi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
by: Lin Bai, et al.
Published: (2020) -
The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China
by: Lin Hu, et al.
Published: (2022) -
Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study
by: Haishaerjiang Wushouer, et al.
Published: (2022) -
Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
by: Cong Huang, et al.
Published: (2022) -
Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015
by: Yue Zhou, et al.
Published: (2020)